Consensus Visteon Corporation

Equities

VC

US92839U2069

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
107.7 USD +0.81% Intraday chart for Visteon Corporation -5.24% -13.78%

Evolution of the average Target Price on Visteon Corporation

Price target over the last 5 years

History of analyst recommendation changes

3ddae986aa506d887eacb505.V0bmV8vV8jhqISvE7OAiZJY3mSdasDFo2qJfyKAyp9Y.YDKhbqa7qmBbU1mmpYR4ItR43Xct4Ggst-gT-8FKz5giL6AclOeTQV1Lfg~cb81cc464b05a913d7f68f217974518b
RBC Cuts Price Target on Visteon to $144 From $146, Keeps Outperform Rating MT
Barclays Upgrades Visteon to Overweight From Equalweight, Raises Price Target to $145 From $140 MT
UBS Trims Visteon's Price Target to $144 From $145, Maintains Buy Rating MT
RBC Lowers Price Target on Visteon to $146 From $188, Notes 2026 Guidance Cut, Keeps Outperform Rating MT
Deutsche Bank Adjusts Visteon Price Target to $142 From $146, Maintains Buy Rating MT
JPMorgan Cuts Visteon Price Target to $148 From $160, Maintains Neutral Rating MT
RBC Lifts Price Target on Visteon to $188 From $187, Keeps Outperform Rating MT
UBS Upgrades Visteon to Buy From Neutral, Adjusts Price Target to $145 From $143 MT
Wolfe Research Downgrades Visteon to Peer Perform From Outperform MT
BNP Paribas Exane Downgrades Visteon to Neutral From Outperform, Price Target is $130 MT
Citigroup Upgrades Visteon to Buy From Neutral, Price Target is $149 MT
Deutsche Bank Adjusts Visteon Price Target to $146 From $176, Maintains Buy Rating MT
Goldman Sachs Trims Price Target on Visteon to $198 From $200, Maintains Buy Rating MT
UBS Cuts Visteon Price Target to $143 From $146, Maintains Neutral Rating MT
RBC Lifts Price Target on Visteon to $187 From $182, Keeps Outperform Rating MT
Citigroup Adjusts Price Target on Visteon to $149 From $160, Maintains Neutral Rating MT
UBS Adjusts Visteon Price Target to $146 From $157, Maintains Neutral Rating MT
Wells Fargo Cuts Price Target on Visteon to $123 From $138, Keeps Underweight Rating MT
UBS Initiates Coverage on Visteon With Neutral Rating, $157 Price Target MT
Barclays Adjusts Price Target on Visteon to $135 From $130, Maintains Underweight Rating MT
RBC Cuts Price Target on Visteon to $182 From $184, Keeps Outperform Rating MT
JPMorgan Adjusts Price Target on Visteon to $157 From $156, Maintains Neutral Rating MT
Citigroup Adjusts Visteon's Price Target to $160 From $159, Keeps Neutral Rating MT
Wells Fargo Adjusts Price Target on Visteon to $130 From $127, Maintains Underweight Rating MT
Wolfe Research Upgrades Visteon to Outperform From Peer Perform, Price Target is $175 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
107.7 USD
Average target price
142.3 USD
Spread / Average Target
+32.14%
High Price Target
161 USD
Spread / Highest target
+49.50%
Low Price Target
106 USD
Spread / Lowest Target
-1.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Visteon Corporation

RBC Capital Markets
Barclays
UBS
Deutsche Bank Securities
JPMorgan Chase
Wolfe Research
BNP Paribas Exane
Citigroup
Goldman Sachs
Wells Fargo Securities
Guggenheim
Berenberg Bank
Morgan Stanley
Baird
BofA Securities
Jefferies & Co.
KeyBanc Capital Markets
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. VC Stock
  4. Consensus Visteon Corporation